Will Allergan Make A Play For Endo?

Allergan’s (AGN) stock has been white hot over the past few months. The stock is up nearly 12% year-to-date due to better than expected Q2 2018 results and attention from the “smart money.” Activist investors Carl Icahn and David Tepper of Appaloosa have been extremely vocal about Allergan’s prospects.